|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 69.01 CNY | -2.91% |
|
-1.85% | -1.82% |
| 01-05 | Xingqi Pharmaceutical Gets Nod for Supplementary Application for Atropine Sulfate Eye Drops | MT |
| 12-08 | Xingqi Pharmaceutical's 39 Products Stay in China's Insurance Drug Catalogue | MT |
Executive Committee: Shenyang Xingqi Pharmaceutical Co.,Ltd.
| Manager | Positions heldSince | ||
|---|---|---|---|
E Gao 52 year |
| ||
Shao Yao Zhang 56 year |
| ||
Ya Nan Cheng 52 year |
| ||
Qiang Yang 42 year |
| ||
Shuo Wang |
| ||
Chun Hua Li 49 year |
|
Composition of the Board of Directors: Shenyang Xingqi Pharmaceutical Co.,Ltd.
| Director | CommitteesSince | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Ji Dong Liu 69 year |
| ||||||||
Xiao Yan Kong 53 year |
| ||||||||
Shao Yao Zhang 56 year |
| ||||||||
Ya Nan Cheng 52 year |
| ||||||||
Xiao Yu Qu 39 year |
| ||||||||
Xiao Bin Dai 69 year |
| ||||||||
Chun Hua Li 49 year |
| ||||||||
Qiang Yang 42 year |
| ||||||||
E Gao 52 year |
|
Latest Appointments: Shenyang Xingqi Pharmaceutical Co.,Ltd.
Former Officers and Directors: Shenyang Xingqi Pharmaceutical Co.,Ltd.
| Insider | Positions held SinceUntil | ||||||
|---|---|---|---|---|---|---|---|
| |||||||
| |||||||
| |||||||
| |||||||
| |||||||
| |||||||
| |||||||
| |||||||
| |||||||
| |||||||
| |||||||
| |||||||
| |||||||
| |||||||
|
Age distribution of managers
Parity Men Women
| Male | 6 |
|---|---|
| Female | 4 |
Of which Executive Committee
| Male | 4 |
|---|---|
| Female | 2 |
Of which Directors
| Male | 5 |
|---|---|
| Female | 4 |
Departures of Key Persons
Chairman
2021-01-06 2024-01-05
Chairman
- 2021-01-05
Chairman
2014-12-31 -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















